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Background: The clinical presentation of dengue is classified by the World Health Organization into dengue without
warning signs, dengue with warning signs and severe dengue. Reports of neurological disease caused by Dengue virus
(DENV) are becoming frequent, with symptoms that include reduced consciousness, severe headache, neck stiffness,
focal neurological signs, tense fontanelle and convulsions. However, the immune mechanisms involved in
neurovirulence remain poorly understood. Here we present a mouse model in which one genotype of DENV is
inoculated by the intracranial route and infects C57/BL6 mice and replicates in the brain, causing death of mice.
Methods: Mice were infected with different serotypes/genotypes of DENV by the intracranial route to evaluate viral
replication, host cytokine and nitric oxide synthase 2 (Nos2) expression in the brain via real-time PCR. Histological
analysis of the brain tissues was also performed. An analysis of which cells were responsible for the expression of
cytokines and Nos2 was performed using flow cytometry. Survival curves of infected animals were also generated.
Results: DENV 3 genotype I infected mice and replicated in the brain, causing death in our murine model. The
increased levels of NOS2 could be the cause of the death of infected mice, as viral replication correlates with increased
Nos2 and cytokine expression in the brain of C57BL/6 mice. In Nos2−/− mice that were infected with DENV, no clinical
signs of infection were observed and cytokines were expressed at low levels, with the exception of interferon gamma
(Ifng). Additionally, the Ifng−/− mice infected with DENV exhibited a severe and lethal disease, similar to the disease
observed in C57BL/6 mice, while the DENV- infected Nos2−/− mice did not display increased mortality. Analyses of the
brains from infected C57BL/6 mice revealed neuronal degeneration and necrosis during histopathologic examination.
IFNg and NOS2 were produced in the brains of infected mice by CD4+ T cells and macrophages, respectively.
Conclusion: The neurovirulence of DENV 3 genotype I is associated with a deleterious role of NOS2 in the brain,
confirming this murine model as an appropriate tool to study DENV neurovirulence.
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The clinical signs of neurological disease caused by Dengue
virus (DENV) are reduced consciousness, severe headache,
neck stiffness, focal neurological signs, tense fontanelle,
and convulsions [1]. The pathophysiology of neurological
involvement in dengue infection is attributed to several fac-
tors, including cerebral edema, cerebral hemorrhage, cere-
bral anoxia, microcapillary hemorrhage, and the release of
toxic products [2]. Therefore, dengue infection is consid-
ered to be a cause of encephalitis and other neurological
manifestations in endemic regions [1,3-12]. Studies have
shown that DENV can interact with various cell types in-
cluding dendritic cells, monocytes, macrophages, hepato-
cytes and endothelial cells [13], resulting in the production
of immune mediators that are present during severe DENV
infection. High levels of cytokines, such as TNF alpha
(TNFa), IFN gamma (IFNg) [14,15], have been detected in
patients with severe dengue. However, it is still not clear
how these cytokines are induced or what these cytokines’
role is in dengue pathogenesis. Despite many in vivo and
in vitro studies that have attempted to determine the role
of various cytokines [9,13,16-18], the lack of small animal
models that simulate dengue human symptoms limits the
dissection of the mechanisms of dengue pathogenesis [11].
Previous work in our laboratory identified DENV-3
genotype I in serum samples from patients in Minas
Gerais classified as having severe dengue; subsequently,
the same genotype was found in naturally infected field-
caught Aedes aegypti mosquitoes and eggs [19,20]. We
previously reported the virulence of low-passage isolates
of DENV-3 genotypes I and III isolated from Brazil in
C57BL/6 mice inoculated by the intracranial (i.c.) route.
We observed that the DENV-3 genotype I isolate caused
neurological disease, whereas infection with the DENV-
3 genotype III isolate was asymptomatic [21].
To better characterize and understand the immuno-
pathology and neurovirulence that occurs in dengue
infected hosts, we used DENV-3 genotype I isolates
obtained from fatal human dengue cases (here named
MG20 and MG21) to experimentally infect mice in this
study, causing a dose-dependent fatal neurological dis-
ease. We also demonstrated that after i.c. inoculation,
the virus isolate MG20 DENV-3 genotype I induced
higher levels of expression of cytokines and pro-
inflammatory mediators including nitric oxide synthase
(NOS2) in the brain. We showed that this virus had re-
duced neurovirulence in Nos2−/− mice. The mortality of
Nos2−/− mice infected with this dengue isolates was re-
duced to zero, in contrast with the mortality of the im-
munocompetent C57BL/6 mice and interferon gamma
(Ifng)−/− mice, which were 80% and 100%, respectively.
These results indicated a correlation between immuno-
pathology and Nos2 expression in the brain when infec-




Dengue virus (DENV-1, BH4); DENV-2 (Pi59); DENV-3
(MG20); DENV-3 (MG21) and DENV-3 (Pi76) isolates
from the sera of dengue patients were obtained from the
collection of the Laboratório de Virus, UFMG and pas-
saged no more than 6 times in C6/36 cells. DENV-1
Mochizuki [22] was kindly provided by Prof. Luiz Tadeu
Figueiredo, USP, SP, Brazil, and DENV-4 (Boa Vista,
1982) [23] was provided by Prof. Mauricio Lacerda
Nogueira, FAMERP, USP, SP, Brazil. Viral stocks were
generated in C6/36 cells infected at a multiplicity of in-
fection (moi) of 0.01. To produce viral stocks, the super-
natant was harvested, cell debris was removed by
centrifugation at 2,000 × g for 5 min, and the viral super-
natant was stored at −70°C.
Cells
C6/36 cells (American Type Culture Collection, Manassas,
VA) were maintained in Leibowitz (L-15) medium (Gibco,
USA) supplemented with 5% heat-inactivated fetal bovine
serum (Cultilab, Brazil) and antibiotics in an incubator at
28°C. These cells were used to support virus replication.
BHK-21 cells (American Type Culture Collection,
Manassas, VA) were maintained in minimal essential
medium (Gibco, USA) supplemented with 5% heat-
inactivated fetal bovine serum (Cultilab, Brazil) and an-
tibiotics in 5% CO2 at 37°C. These cells were used for
virus titration.
Mice
All of the animal experiments were approved based on
the regulations and guidelines of the Ethical and Animal
Use Committee on Animal Experimentation (CETEA/
UFMG 026/2011).
C57BL/6 (WT) mice were obtained from Centro de
Bioterismo–Universidade Federal de Minas Gerais (MG,
Brazil). The Nos2−/− and Ifng−/− mice on the C57BL/6 back-
ground were obtained from Centro de Criação de Animais
de Laboratório–Fundação Oswaldo Cruz (RJ, Brazil). Male
mice at 8–10 weeks of age were inoculated via the intra-
cranial route with 20 μL of the virus or uninfected C6/36
cell supernatants as a control. The mice were anesthetized
using ketamine (Agribrands do Brasil Ltda, Brazil).
Plaque reduction neutralization test (PRNT50)
The plaque assay in BHK-21 cells was performed using a
protocol that was modified from Russell and others
(1967) [24]. Briefly, BHK-21 cells were seeded into 24-
well plates at a density of 1 × 105 cells/well and incu-
bated overnight at 37°C in 5% CO2 until the cells were
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were inactivated at 56°C for 30 min and serially diluted
in 2-fold steps (1:20 to 1:120), and the virus (containing
40–60 pfu of DENV-3) was preincubated with the sera
in a final volume of 360 μL for 1 h at room temperature.
The cell monolayer was washed with PBS, and 150 μL of
the virus and serum mixture was added to the cells for 1 h
at 37°C and overlaid with 1 ml per well of MEM containing
1.5% FBS, 1.5% carboxymethyl cellulose (Sigma-Aldrich,
USA) and antibiotics. The plates were incubated for 5 days
at 37°C in 5% CO2. Controls were included, and the test
was performed in duplicate. The cells were fixed with 4%
formalin for 1 hour and stained with 0.8% crystal violet
(Sigma-Aldrich, USA) for 15 min. The plaque counts were
averaged and are presented in Units per ml, which corre-
sponds to the reciprocal of the dilution that neutralized 50
percent of the plates in 1 ml serum.
RNA extraction
The brains were aseptically removed from mice and stored
at −70°C until processing. RNA extraction was performed
using the TRIzol reagent (Invitrogen) according to the
manufacturer’s instructions. The extracted RNA was
quantified with a Nanodrop ND-1000 spectrophotometer
(Thermo Scientific) at 260 and 280 nm.
Reverse transcription
Reverse transcription was performed according to the
procedures provided by the manufacturer of the M-MLV
RT enzyme (Promega, Madison, WI) using 3 μg of RNA.
Real-time PCR
Real-time PCR [25] was performed to measure the mRNA
expression levels of cytokines, chemokines and Nos2 and
to measure the 5’UTR genomic region of DENV in the
indicated mice. The reactions were performed using
the SYBR Green PCR Master Mix (Applied Biosystems,
Carlsbad, CA) in a Step One real-time PCR System and
the reaction conditions were 50°C for 2 minutes, 95°C for
10 minutes, and 40 cycles of 95°C for 15 minutes and 60°C
for 1 minute, followed by a final dissociation stage. The
following oligonucleotides were used in the reactions:
Hypoxanthine-guanine phosphoribosyl transferase (Hprt)
(forward: 5’-GTTGGATACAGGCCAGACTTTGTTG-3’;
reverse: 5’-GATTCAACTTGCGCTCATCTTAGGC-3’);
Ifnb (forward: 5’-CTGGAGCAGCTGAATGGAAA-3’; re-
verse: 5’-GTCTGCTGGTGGAGTTCAT-3’); Cxcl10 (for-
ward: 5’-GCCGTCATTTTCTGCCTCAT-3’; reverse: 5’-G
CTTCCCTATGGCCCTCATT-3’); Ccl2 (forward: 5’-CTT
CTGGGCCTGCTGTTCA-3’; reverse: 5’-CCAGCCTACT
CATTGGGATCA-3’); Ccl3 (forward: 5’-ACTGCCTGCT
GCTTCTCCTA-3’; reverse: 5’-TTGGAGTCAGCGCAGA
TCTG-3’); Il1b (forward: 5’-CGCAGCAGCACATCAA
CAAGAGC-3’; reverse: 5’-TGTCCTCATCCTGGAAGGTCCACG-3’); Ifng (forward: 5’- TCAAGTGGCATAGAT
GTGGAAGAA-3’; reverse: 5’- TGGCTCTGCAGGATTT
TCATG-3’); Tnfa (forward: 5’- CATCTTCTCAAAATTC
GAGTGACAA-3’; reverse: 5’- TGGGAGTAGACAAGGT
ACAACCC-3’); Ccl5 (forward: 5’- GCAAGTGCTCCAA
TCTTGCA-3’; reverse: 5’- CTTCTCTGGGTTGGCACA
CA-3’); Nos2 (forward: 5’- CAGCTGGGCTGTACAAAC
CTT-3’; reverse: 5’- CATTGGAAGTGAAGCGTTTCG-3’);
and 5’UTR region of DENV (forward: 5’- TCGGAAGC
TTGCTTAACGTAG-3’; and reverse: 5’- TCCGTTGGTT
GTTCATCAGA-3’). The relative quantification method-
ology was used to analyze the data. Gene or viral RNA
expression was normalized to the expression level of the
constitutively expressed gene Hprt. All reactions were
replicated.Cell preparation and flow cytometry
On the 8th day post infection (d.p.i.), mice were anesthe-
tized and perfused with phosphate-buffered saline (PBS).
Brains were removed and the adherent leukocytes were
isolated using a previously described protocol [26]. Ali-
quots of these leukocytes were incubated with APC-
labeled anti-mouse F4/80 (eBioscience, USA) to identify
macrophages, FITC-labeled anti-mouse NK1.1 (BD
Pharmingen, USA) to identify NK cells, APC-labeled anti-
mouse CD4 (eBioscience, USA) to identify helper T cells,
and PECy5-labeled anti-mouse CD8 (BD Pharmingen,
USA) to identify cytotoxic T cells. The cells were washed
and fixed with FACS FIX Solution (BD Pharmingen,
USA). After fixation the leukocytes were washed twice and
submitted to permeabilization by the addition of 150 μL of
Perm buffer (FACS buffer supplemented with 0.5% sap-
onin, Sigma-Aldrich, USA) for 10 min. at room tem-
perature. The leukocytes were then incubated with 20 μL
of PE-labeled anti-IFNg and FITC-labeled anti-NOS2 (BD
Pharmingen, USA) for 15 minutes at 4°C in the dark. After
two wash steps, the cells were fixed with FACS FIX
Solution and stored at 4°C for cytometric acquisition. One
hundred thousand events were acquired for each sample.
A FACS Calibur (Becton Dickinson, CA, USA) with
CellQuest™ software was used for acquisition and the data
were analyzed using the FlowJo 7.2.5 software (Tree Star,
Inc., Ashland, OR) and are presented as the percentage of
positive cells within the gated population.Histological analysis
Brain fragments were fixed in 10% neutral-buffered for-
malin and processed for paraffin embedding. The brain
sagittal sections (4 μm) were stained with hematoxylin
and eosin (H&E). The images were acquired using an
Olympus BX51 microscope and the Image-Pro Express
4.0 (Media Cybernetics, MD, USA) software.
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Twelve images per specimen were obtained, and perivas-
cular inflammatory areas, which are areas of increased
cellularity in the parenchyma immediately close to a
small vessel, were manually measured using the Image J
1.45S software (NIH, USA), and expressed as the inflam-
matory area per 100 μm2 of brain tissue. Data from the
different groups were compared with one-way analysis
of variance (ANOVA) (GraphPad Prism software; San
Diego, USA). Statistical significance was set at P < 0.05
when comparing the data from the 8th d.p.i. in C57BL/6
mice with all of the other bars.
Statistical analysis
Real-time PCR was statistically analyzed using the
Kruskal-Wallis nonparametric tests and Dunn’s multiple
comparison tests. Kaplan-Meier survival curves were used
to display the survival data, and log rank analyses were
employed to determine the statistical significance between
the experimental groups. To analyze flow cytometry re-
sults, nonparametric two-way ANOVA tests and the
Bonferroni post-hoc test were performed. The analysesA
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Figure 1 The genotype I of DENV-3 (MG20) isolate is neurovirulent. N
susceptible to infection. Mice were intracranially (i.c.) inoculated with DENV
C6/36 cell supernatants were used as controls (n = 5 for all the groups). (A)
** P < 0.01 when comparing 4 × 102 DENV-3 (MG20) and 4 × 102 DENV-3 (M
4 × 10 DENV-3 (MG20), 4 × 10 DENV-3 (MG21) or the three different doses u
DENV-3 (MG20) or DENV-1 (Hotta, 1951). *P <0.05, when comparing DENV-
animals. (C) 4 × 102 pfu of DENV-3 (MG20) in C57BL/6 (WT), Ifng−/− and Nos
WT mice or with Ifng−/− mice (D) Body weight was expressed as a percent
analyzed using the Kaplan-Meier method followed by log-rank tests. The rewere conducted using GraphPad Prism 5 software for
Windows (GraphPad Software, Inc., La Jolla, CA).
Results
Nitric oxide synthase expression correlates with death in
a mouse experimental model of dengue with CNS
involvement
C57BL/6 (WT) mice were i.c. inoculated with concentra-
tions from 4 × 10 to 4 × 103 pfu of low-passage isolates
of DENV-1 (BH4); DENV-2 (Pi59); DENV-4 (Boa Vista,
1982), DENV-3 genotype I (MG20), DENV-3 genotype I
(MG21), or DENV-3 genotype III (Pi76). The mice were
monitored daily to determine their susceptibility to in-
fection and to observe clinical signs of infection such as
weight loss, lethargy, ruffled fur and a hunched posture.
Inoculation of mice with uninfected C6/36 cell superna-
tants were used as controls. Only DENV-3 genotype I
(MG20 and MG21)-infected mice exhibited clinical signs
and mortality when doses of 4 × 103 pfu (100% mortality)
or 4 × 102 pfu (80% mortality) were used (Figure 1A).
After infection, the mice gradually developed anorexia,
asthenia and lost weight. From the 6th to the 8th dayB


















































os2−/− mice are resistant to infection, while Ifng−/− and WT mice are
and monitored daily until 15 d.p.i. Mice inoculated with uninfected
4 × 103 to 4 × 10 pfu of DENV-3 (MG20, Pi76 or MG21). * P < 0.05,
G21) or 4 × 103 DENV-3 (MG20) and 4 × 103 DENV-3 (MG21) with
sed in the DENV-3 (Pi76), or the cell supernatant. (B) 4 × 102 pfu of
1 or DENV-3 (MG20)-infected animals to the supernatant-inoculated
2−/− mice. *P < 0.05 and P < 0.001, when comparing Nos2−/− mice with
age of the initial weight of the animal. Survival curves were statistically
sults are representative of two similar and independent experiments.
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with 4 × 102 pfu of DENV-3 genotype I presented ruffled
fur, hunched postures and loss of balance followed by
paralysis. Most of these mice died 12–24 hours after the
onset of paralysis, which was approximately the 10th
d.p.i. Mice that were infected with DENV serotypes 1, 2,
or 4, with DENV-3 genotype III, or the C6/36 cell super-
natant showed no clinical signs or mortality (Figure 1A).
The results demonstrate a significant difference (P <
0.05) between the survival curves of mice after infection
with 4 × 102 pfu of DENV-3 genotype I (MG20 or
MG21) and the survival curves representing the mice
infected other DENV types. In mice infected with lethal
doses of DENV-3 genotype I, a clear correlation between
the viral dose and the time of death was observed. Mice
infected with 4 × 102 pfu of DENV-1 Mochizuki, a
neurovirulent mouse-adapted strain isolated in 1943 in
Japan [22], presented neurological clinical signs and
mortality that were similar to those of mice infected
with 4 × 102 pfu of DENV-3 genotype I (Figure 1B). Ni-
tric oxide (NO) is synthesized by macrophages after in-
duction of NOS2 by IFN gamma [27,28], and NO has
antiviral activities against encephalitic viruses [29]. Thus,
Nos2–/– and Ifng–/– mice, both on a C57BL/6 background,
were also infected with 4 × 102 pfu of DENV-3 genotype
I (MG20) and observed daily for the above cited clinical
signs of encephalitis and mortality (Figure 1C). Infected
WT, Ifng−/− and Nos2−/− mice were monitored for weight
loss over a period of 15 days (Figure 1D). Infected WT
and Ifng−/− mice presented clinical signs of infection and
mortality. WT and Ifng−/− mice, which were similar to
WT mice, exhibited weight loss starting on the 5th d.p.i.
(Figure 1D), progressing to lethargy, ruffled fur and
hunched postures with posterior paw paralysis and death
between the 7th and 10th d.p.i. (Figure 1C). Only 20% of
the infected WT mice survived. Surprisingly, 100% of
the Nos2−/− mice survived infection with DENV-3 geno-
type I (Figure 1C) without exhibiting any clinical signs of
infection or weight loss until the 15th d.p.i. (Figure 1D).
There were significant differences in the mortality rates
between the infected WT and Nos2−/− mice (P < 0.05),
suggesting a pathological role for NO in DENV-3 geno-
type I-induced neurological disease. To prove that the
infection was successful in the infected Nos2−/− mice, a
plaque reduction neutralization test (PRNT50) was per-
formed using sera from the Nos2−/− mice at the 30th
d.p.i. The titers obtained in this assay were greater than
100 U/ml.
DENV-3 genotype I (MG20) replicates in the brain,
inducing increases in Nos2 and pro-inflammatory
cytokine expression levels
Four WT infected mice per group were euthanized each
day for eight days after infection and analyzed to verifythe expression levels of virus genes, cytokines and Nos2
transcripts by real-time PCR. Mice inoculated with unin-
fected C6/36 cell supernatants were used as controls.
Quantitative PCR allowed the detection of viral tran-
scripts in the mouse brains starting on the 2nd d.p.i. and
revealed an increasing viral load up to 8 days after infec-
tion (Figure 2A). The transcript for cytokine genes Ccl5,
Cxcl10, Ccl3, Ifng, Ifnb, and Tnfa in the mouse brain
showed a similar profile, with increased expression levels
between the 7th and 8th d.p.i. (Figure 2B-D, F-H). The
increased transcript levels were statistically significant
for all of the cytokines. The level of the Nos2 transcript
was higher on the 7th and 8th d.p.i. and was significant
when compared to mice inoculated with uninfected C6/
36 cell supernatants (Figure 2E). The presence of virus
appears to correlate with increased Nos2 and cytokine
expression in the brain of WT mice between the 7th and
8th d.p.i. (Figure 2).
Nos2−/− mice infected with DENV-3 genotype I presented
no clinical signs, although high viral titers were found in
the brain at the 8th d.p.i.
In contrast with the DENV-3-infected WT mice, 100% of
the Nos2−/− mice survived the infection, without exhibiting
any clinical signs until the 30th d.p.i. To verify whether the
virus replicates in the brains of Nos2−/− mice, these mice
were infected with 4 × 102 pfu of DENV-3 genotype I and
euthanized on the 8th d.p.i., which corresponds to the peak
of viral replication in the WT mouse brains. Mice inocu-
lated with uninfected C6/36 cell supernatants were used as
controls. No differences in the viral load were detected in
the brains of the WT and Nos2−/− mice (Figure 3A). These
results suggest a neuropathological role for NOS2 in
DENV infection. The brains of infected mice that were eu-
thanized on the 8th d.p.i. were analyzed by real-time PCR
to verify whether there were different levels of cytokine ex-
pression in the infected WT and Nos2–/– mice. The levels
of pro-inflammatory cytokine expression increased consist-
ently on the 8th d.p.i. in only the infected WT mice
(Figure 3B-E, Figure 3G), with exception of Ifng, which in-
creased in both the WTand in Nos2−/− mice (Figure 3F).
Fewer histopathological alterations were found in Nos2−/−
mice infected with DENV-3 genotype I (MG20)
One-half of each infected brain from the mice that were
euthanized on the 5th and 8th d.p.i. was formalin fixed for
histopathological analysis. Brain sections from the mice
that were inoculated with the uninfected C6/36 cell super-
natant did not display any pathological changes at any
time post-infection (Figure 4A and B). Histological ana-
lysis of the brains that were excised on the 5th d.p.i. from
WT mice that were infected with DENV-3 genotype I re-
vealed the preservation of nervous tissue with hyperemia,
perivascular edema, and a sparse inflammatory infiltrate
Figure 2 Immunological profile of WT mice infected with DENV-3 (MG20). Mice were i.c. inoculated with 4 × 102 pfu of DENV-3 (MG20) and
the brains of 4 animals per group were collected each day until the 8th d.p.i. Mice inoculated with uninfected C6/36 cell supernatants were used
as controls. RNA was extracted from the brains and reverse transcription and quantitative PCR were performed. (A) viral RNA (B) Ccl3; (C) Cxcl10;
(D) Ccl3; (E) Nos2; (F) Ifng; (G) Ifnb; (H) Tnfa. *P < 0.05, **P < 0.001 or ***P < 0.0001 when the infected mice were compared with the uninfected
control mice (N.I.). The results are representative of two similar and independent experiments. Statistical analyses were performed using Kruskal-
Wallis nonparametric tests and Dunn’s multiple comparison tests. Bars represent the SEM.
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flammatory foci containing mononuclear cells could be
detected in the meninges without involvement of the sub-
jacent parenchyma. The histological analysis of brains
from DENV-3-infected Nos2−/− mice on the 5th d.p.i. did
not differ from the brains of infected WT mice at the
same time point (Figure 4G and H). At 8 d.p.i., the
brains from DENV-3-infected WT mice exhibited diffuse
and intense inflammation and edema of the nervous tissue,Figure 3 Nos2−/− mice infected with DENV expressed lower levels of c
and Nos2–/– mice were i.c. inoculated with 4 × 102 pfu of DENV-3 (MG20) a
Mice inoculated with uninfected C6/36 cell supernatants were used as con
quantitative PCR were performed. (A) Infectious virus titers were determine
the 8th d.p.i.; (B) Ifnb; (C) Ccl3; (D) Ccl5; (E) Cxcl10; (F) Ifng; (G) Tnfa. * P < 0.
control mice (N.I.). ≠ P < 0.05 when the infected WT mice were compared
similar and independent experiments. Statistical analyses were performed u
comparison tests. Bars represent the SEM.vessels and meninges (Figure 4E and F). Meningitis was
characterized by several large inflammatory foci containing
mononuclear and polymorphonuclear cells. In the paren-
chyma, intense vascular alterations, intracellular and
pericellular edema, and degenerative changes in neurons
and glial cells could be observed, although the inflamma-
tory foci were rare and discrete. Vacuoles in the white
and gray matter, irregular areas of necrosis, hemorrhage
and recent thrombosis could be detected throughout theytokines than WT mice, with exception of Ifng expression. WT
nd the brains of 4 animals per group were collected at the 8th d.p.i.
trols. RNA was extracted from the brains and reverse transcription and
d as pfu/g of brains of the DENV-3 infected WT and Nos2−/− mice at
05 when the infected mice were compared with the uninfected
to the Nos2−/− infected mice. The results are representative of two




































Figure 4 Histopathological alterations that indicate neurovirulence were reduced in Nos2−/− mice infected with DENV. Mice were i.c.
inoculated with 4 × 102 pfu of DENV-3 (MG20). The brains of 4 animals per group were collected at day 5 or 8 post-infection (d.p.i.) and routinely
processed for histopathological analysis. Mice inoculated with uninfected C6/36 cell supernatants were used as controls. Collected mice brains: A and
B-Uninfected; C and D-DENV-3-infected WT at 5th d.p.i.; E and F- DENV-3-infected WT at 8th d.p.i.; G and H-DENV-3-infected Nos2−/− at 5th d.p.i.; I and
J-DENV-3-infected Nos−/− at 8th d.p.i. Histopathological alterations were not observed in the brains of uninfected WT mice (A and B). Note the
endothelial response (thick arrows) and perivascular leukocyte cell migration (thin arrows) as well as the intense vacuolization of the brain tissue
(arrowhead), suggesting neuronal degeneration, necrosis, and apoptosis (*) (E and F). The images were captured at different magnifications, bar = 10
micrometers. (K) The area of the lesion was expressed as the inflammatory area per 100 μm2 of brain tissue. The results are representative of two
similar and independent experiments. Data from the different groups were compared using a one-way analysis of variance (ANOVA) (GraphPad Prism
software, San Diego, USA). *P < 0.05 when comparing the 8th d.p.i. in the WT mice with the other bars. N.I. = uninfected.
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-infected Nos2−/− mice did not present the histopatho-
logical alterations that were observed in the brains from
infected WT mice (Figure 4I and J). The infected Nos2−/−
brain parenchyma exhibited few isolated necrotic or apop-
totic areas, discrete perivascular inflammatory infiltrates,
edema and vascular alterations.Increased levels of IFN gamma and NOS2 in the brains of
infected mice are produced by CD4+ T cells and
macrophages, respectively
To study the cell populations and the cytokine expression
by the cells in the brains of infected mice, we used flow
cytometric analysis. This analysis showed that there were
more CD4+ T cells producing IFN gamma in the brains of
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infected WT or Nos2−/− mice. There was no difference in
the number of CD4+ T cells producing IFN gamma in the
brains of infected WT mice compared with the brains of
infected Nos2–/– mice (Figure 5A). Natural killer cells and
CD8+ T cells were also present in the brain, but the per-
centage of these cells producing IFN gamma did not differ
between the groups of mice (Figure 5B and C). The per-
centage of macrophages producing NOS2 in infected WT
mouse brains was significantly higher than in the brains of
non-infected WT mice (Figure 5D).
Discussion
To date, some unique symptoms of dengue remain poorly
explained. Thus, the previous guidelines for the classifica-
tion of dengue diagnosis as DF, DHF and DSS were re-
cently modified by the World Health Organization to
dengue without warning signs, dengue with warning signs
and severe dengue [12]. One of the criteria for severe den-
gue is involvement of the central nervous system (CNS)
with impaired consciousness. Several reports exist in the
literature of CNS involvement following dengue infection:
4% of 378 patients suspected of CNS infection [1], 9.5% of
children with viral encephalitis [5], and 48% of 150 fatal
cases including CNS involvement [4] were positive for
dengue. In two other reports, 5% [6] and 13.5% of total
dengue patients [7] were identified as having CNS involve-
ment. However, there are serious difficulties in the study
of dengue in animal models that include the immune re-
sponse and immunopathology of dengue with CNS in-
volvement, generally because unmodified DENV does not
infect or cause symptoms in laboratory animals. Mouse
models of dengue infection have been extensively ex-
plored, but none of these models has reproduced all of the






































Figure 5 DENV induces production of IFNg by CD4+ T cells and NOS2
DENV-3 (MG20) and the brains of 4 animals per group were collected on th
were used as controls. The brains were treated with collagenase and Perco
cells in the various cell populations was analyzed by flow cytometry: (A) IF
NOS2 in macrophages. *P < 0.05 and **P < 0.001 when comparing the infec
comparing the infected versus uninfected WT and the infected Nos2−/− mi
using nonparametric two-way ANOVA tests and the Bonferroni post-hoc tethat are observed in humans [30,31]. Cell culture passage
and mouse adaptation allows the infection with a virus
that mimics human disease in mice [29,32,33]. However,
the alteration of virulence characteristics of the virus can
impair the study of induced pathologies that depend on
the viral strain, as is the case with neurovirulence. In the
present study, we characterized the fatal neurovirulence of
non-mouse-adapted DENV-3 (MG20) genotype I that was
delivered by i.c. infection of C57BL/6 (WT) mice. Nos2−/−
mice were resistant to this virus. DENV-3 MG20 was ori-
ginally isolated in 2004 from the serum of a fatal human
dengue case in Belo Horizonte (MG, Brazil) that had
CNS involvement [19]. Although neurological manifes-
tations have been described in dengue, the disease’s
true prevalence is unknown due to under-recognition
of CNS presentations. Interestingly, the same clinical
signs and mortality were observed in the DENV-3
MG20 infection in our study as were observed in
DENV-1 Mochizuki-infected mice [22], a classical
model of neurovirulence in mice.
In our model, immunocompetent mice had high levels
of pro-inflammatory cytokine expression in the brain
after infection with DENV-3 (MG20). The cytokine and
viral gene transcripts exhibited a similar profile with in-
creased expression levels peaking at the 7th to 8th d.p.i.
and a concomitant increase in viral replication, paralysis,
and neural tissue damage, culminating in death, demon-
strating the involvement of the immune system in the
pathogenesis after infection with DENV-3 (MG20). Mol-
ecules such as IFN gamma and TNF alpha appear to be
markers for the different degrees of dengue disease or
the dengue prognosis [14,34]. The DENV-3 (MG20)-
infected IFN-g−/− mice were susceptible to infection and
exhibited 100% mortality, presenting the same clinical




















by macrophages. Mice were i.c. inoculated with 4 × 102 pfu of
e 8th d.p.i. Mice inoculated with uninfected C6/36 cell supernatants
ll (Sigma-Aldrich) and the percentage of IFNg- and NOS2-producing
Ng in CD4+ T cells; (B) IFNg in CD8+ T cells; (C) IFNg in NK cells; (D)
ted mice to the uninfected mice (A-C). (D) ***P < 0.0001 when
ce versus the infected WT mice. Statistical analyses were performed
st.
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DENV-3 (MG20) revealed the presence of inflammatory
infiltrates and edema in infected WT and Nos2−/− mice
on the 5th d.p.i. However, on the 8th d.p.i., the brains of
the infected WT mice showed an intense endothelial re-
sponse with perivascular polymorphonuclear cells,
mononuclear leukocyte cell migration, meningitis and
intense vacuolization that suggested neuronal degener-
ation, necrosis, and apoptosis. By contrast, the Nos2−/−
DENV-infected mice presented only mild histopatho-
logical changes in their brains at the 8th d.p.i. As the
disease progressed, the infected WT animals appeared
to be lethargic and displayed reduced motility. This fac-
tor may have resulted in reduced water intake and dehy-
dration of the animals, contributing to the weight loss
observed near the moribund stage, and consequently
leading to death of the animals. We demonstrated in-
tense vacuolization in the brains of infected mice,
suggesting neuronal degeneration, necrosis, and apop-
tosis. Furthermore, increased Nos2 expression at the 8th
d.p.i. was observed, accompanied by a worsening of the
clinical signs and a peak viral load in the brain. Nos2 is
responsible for the cytotoxic action of macrophages and
neutrophils, and nitric oxide (NO) has been implicated
in neurodegeneration and chronic inflammation in a
mouse model of neurotoxicity. When NO production is
associated with TNF alpha and IFN gamma in the brain,
cerebral damage is caused, which induces an increase in
the expression of the genes encoding pro-inflammatory
molecules [35]. At optimal doses and when acting on
cells of an organ able to regenerate quickly, NO has a
protective and regulatory function; however, NO has
toxic effects at higher concentrations [36] and when
acting on cells of an organ which has difficulty regener-
ating such as the brain. Our results demonstrated that
100% of the Nos2–/– mice survived infection with the
DENV-3 (MG20) without exhibiting any clinical signs
until the 15th d.p.i. Moreover, flow cytometric analysis
revealed that CD4+ T cells, CD8+ T cells and macro-
phages were present in the brains of infected mice and
that the CD4+ T cells were responsible for producing
IFN gamma, which most likely induced the production
of NOS2 by the WT mouse macrophages in response to
DENV infection. Furthermore, the infected Nos2−/−
mice displayed no significant increase in cytokine tran-
scripts in their brains with the exception of the Ifng
transcript, which was also expressed at a higher level
than in uninfected mice. These Nos2-deficient animals
exhibited fewer histopathological alterations following
infection, confirming the importance of NOS2 in the
neuropathogenesis of neurovirulent DENV. By contrast,
when mouse-adapted DENV-3 [32] was intraperitone-
ally injected into the Nos2−/− mice, 100% mortality was
observed, indicating that the virus isolate (DENV-3genotype I or adapted DENV-3) and the route of inocu-
lation (intracranial or intraperitoneal) are distinct vari-
ables responsible for these contrasting results. Indeed,
each mouse model represents a unique tool to study the
various patterns of pathologies caused by DENV.
Thus, i.c. infection of immunocompetent mice with a
DENV isolate that causes CNS disease can be used as a
tool to study the immune response, immunopathological
manifestations, and neurological manifestations of den-
gue infection that are increasingly being reported in en-
demic dengue regions.
Conclusions
In conclusion, DENV-3 genotype I (MG20) induces a
virulent infection with CNS involvement and results in
death of immunocompetent mice at a low viral dose and
without requiring adaptation of the virus to mice. Nitric
oxide synthase 2 is deleterious for the host in this ex-
perimental mouse infection model. Notably, our data in-
dicate that this mouse model may be a useful tool for
studying the immunopathology of dengue in the CNS.
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